NewsCoronavirus

Actions

Single-shot COVID-19 vaccine candidate moves to Phase 3 testing

Single-shot COVID-19 vaccine candidate moves to Phase 3 testing
Posted
and last updated

Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus.

It will be one of the world’s largest coronavirus vaccine studies so far, testing in 60,000 volunteers in the U.S., South Africa, Argentina, Brazil, Chile, Colombia, Mexico and Peru.

A handful of other vaccines in the U.S. and elsewhere are already in final testing. The two other vaccine candidates in final-phase testing in the U.S. — candidates made by Moderna and Pfizer — were both approved in July. Earlier this month, Dr. Anthony Fauci said those trials should be filled by the end of September, meaning they should be completed by late November or early December.

Hopes are high that answers about at least one could come by year’s end, maybe sooner.

U.S. health officials insist the race for a vaccine isn’t cutting corners, despite enormous political pressure.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Tuesday

07/01/2025

Mostly Clear

-° / 72°

0%

Wednesday

07/02/2025

Clear

103° / 73°

0%

Thursday

07/03/2025

Clear

102° / 69°

0%

Friday

07/04/2025

Clear

96° / 66°

0%

Saturday

07/05/2025

Clear

96° / 68°

0%

Sunday

07/06/2025

Clear

99° / 70°

0%

Monday

07/07/2025

Clear

101° / 71°

0%

Tuesday

07/08/2025

Clear

102° / 72°

0%